Cargando…

Prognostic value of CDCA3 in kidney renal papillary cell carcinoma

Kidney renal papillary cell carcinoma (KIRP) is a type of low-grade malignant renal cell carcinoma. Huge challenges remain in the treatment of KIRP. Cell division cycle associated 3 (CDCA3) participates in human physiological and pathological processes. However, its role in KIRP has not been establi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hao, Li, Mi, Yang, Caihong, Guo, Fengjing, Deng, Sisi, Li, Lixi, Ma, Tian, Yan, Jiyuan, Wu, Hua, Li, Xiaojuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714141/ https://www.ncbi.nlm.nih.gov/pubmed/34905505 http://dx.doi.org/10.18632/aging.203767

Ejemplares similares

Comprehensive Analysis of ATP6V1s Family Members in Renal Clear Cell Carcinoma With Prognostic Values
por: Li, Xiaojuan, et al.
Publicado: (2020)

Prognostic value of IKBIP in papillary renal cell carcinoma
por: Zhang, Huiling, et al.
Publicado: (2023)

Comprehensive Analysis of Key Genes and Regulatory Elements in Osteosarcoma Affected by Bone Matrix Mineral With Prognostic Values
por: Li, Mi, et al.
Publicado: (2020)

Key genes with prognostic values in suppression of osteosarcoma metastasis using comprehensive analysis
por: Li, Mi, et al.
Publicado: (2020)

CDCA1/2/3/5/7/8 as novel prognostic biomarkers and CDCA4/6 as potential targets for gastric cancer
por: Li, Zhaoxing, et al.
Publicado: (2021)

Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
por: Yu, Zhenjun, et al.
Publicado: (2021)

Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient
por: Phan, Nam Nhut, et al.
Publicado: (2018)

CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker
por: Hu, Hao, et al.
Publicado: (2022)

CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma
por: Wang, Zhihuai, et al.
Publicado: (2021)

CDCA2 acts as an oncogene and induces proliferation of clear cell renal cell carcinoma cells
por: Li, Fang, et al.
Publicado: (2020)

CDCA3 is a prognostic biomarker for cutaneous melanoma and is connected with immune infiltration
por: Li, Tianhao, et al.
Publicado: (2023)

Hypoxia promotes maintenance of the chondrogenic phenotype in rat growth plate chondrocytes through the HIF-1α/YAP signaling pathway
por: Li, Hao, et al.
Publicado: (2018)

CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker
por: Shen, Zhiqing, et al.
Publicado: (2018)

Borealin/CDCA8 deficiency alters thyroid development and results in papillary tumor-like structures
por: Didier-Mathon, Hortense, et al.
Publicado: (2023)

The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
por: Jin, Xin, et al.
Publicado: (2022)

Comprehensive analysis of LAMC1 expression and prognostic value in kidney renal papillary cell carcinoma and clear cell carcinoma
por: Bai, Jianrong, et al.
Publicado: (2022)

A pan-cancer analysis reveals the diagnostic and prognostic role of CDCA2 in low-grade glioma
por: Li, Wenle, et al.
Publicado: (2023)

Identification and verification of prognostic cancer subtype based on multi-omics analysis for kidney renal papillary cell carcinoma
por: Wang, Baodong, et al.
Publicado: (2023)

The role of the CDCA gene family in ovarian cancer
por: Chen, Chongxiang, et al.
Publicado: (2020)

Differential prognostic value of MYC immunohistochemistry in subtypes of papillary renal cell carcinoma
por: Bellut, Julia, et al.
Publicado: (2017)

Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma
por: Wang, Jianlin, et al.
Publicado: (2018)

Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma
por: Wang, Yue, et al.
Publicado: (2023)

Prognostic models in papillary renal cell carcinoma
por: Attalla, Kyrollis, et al.
Publicado: (2020)

Prognostic impact of LY6K and CDCA1 expression for patients with esophageal squamous cell carcinoma
por: Oguma, Junya, et al.
Publicado: (2020)

CDCA3 Predicts Poor Prognosis and Affects CD8(+) T Cell Infiltration in Renal Cell Carcinoma
por: Bai, Yuanyuan, et al.
Publicado: (2022)

Prognostic and Immunological Roles of Cell Cycle Regulator CDCA5 in Human Solid Tumors
por: He, Jing, et al.
Publicado: (2022)

The inhibitory effect of silencing CDCA3 on migration and proliferation in bladder urothelial carcinoma
por: Shen, Dexin, et al.
Publicado: (2021)

Pan-cancer analysis identifies CDCA3 as a novel prognostic marker associated with immune infiltration in lung adenocarcinoma through bioinformatics analysis
por: Yang, Hao, et al.
Publicado: (2022)

Construction of a prognostic value model in papillary renal cell carcinoma by immune-related genes
por: Wang, Leilei, et al.
Publicado: (2021)

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
por: Tian, Yunhong, et al.
Publicado: (2018)

CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma
por: Zhou, Fenfang, et al.
Publicado: (2021)

The prognostic value of the lymphocyte-to-monocyte ratio for high-risk papillary thyroid carcinoma
por: Song, Linlin, et al.
Publicado: (2019)

KIF22 promotes bladder cancer progression by activating the expression of CDCA3
por: Li, Kai, et al.
Publicado: (2021)

Key Prognostic Value of Lysosomal Protein Transmembrane 5 in Kidney Renal Clear Cell Carcinoma
por: Li, Bin, et al.
Publicado: (2022)

Integrated Analysis of a Competing Endogenous RNA Network Reveals a Prognostic Signature in Kidney Renal Papillary Cell Carcinoma
por: He, Ruyi, et al.
Publicado: (2020)

CDCA8 expression and its clinical relevance in patients with bladder cancer
por: Bi, Yaqiong, et al.
Publicado: (2018)

VENUSS rising for papillary renal cell carcinoma prognostication?
por: Buchler, Tomas
Publicado: (2020)

CDCA7L promotes glioma proliferation by targeting CCND1 and predicts an unfavorable prognosis
por: Ji, Qian-Kun, et al.
Publicado: (2019)

Identification of an independent autophagy-gene prognostic index for papillary renal cell carcinoma
por: Wei, Xiyi, et al.
Publicado: (2020)

CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway
por: Ji, Junpeng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8vg23g7qig185q1a932jgbei86